Hence, considering resveratrol's ability to counteract the factors contributing to CD44‐induced treatment resistance (refer to Figure 1), enhance cancer cell apoptosis through increased ROS, and improve the efficacy of platinum‐based chemotherapeutic drugs highlights its potential as a chemo‐sensitizer for carboplatin treatment in advanced or metastatic stage cervical cancer. The gene discussed is CD44; the disease is cervical carcinoma.